Müller, Annelies; Salmen, Anke; Aebi, Susanne; de Gouveia, Linda; von Gottberg, Anne; Hathaway, Lucy J. (2020). Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid. BMC microbiology, 20(1), p. 16. BioMed Central 10.1186/s12866-020-1700-7
|
Text
Müller et al 2020.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (892kB) | Preview |
Background: The polysaccharide capsule is a major virulence factor of S. pneumoniae in diseases such as meningitis. While some capsular serotypes are more often found in invasive disease, high case fatality rates are associated with those serotypes more commonly found in asymptomatic colonization. We tested whether growth patterns and capsule size in human cerebrospinal fluid depends on serotype using a clinical isolate of S. pneumoniae and its capsule switch mutants.
Results: We found that the growth pattern differed markedly from that in culture medium by lacking the exponential and lysis phases. Growth in human cerebrospinal fluid was reduced when strains lost their capsules. When a capsule was present, growth was serotype-specific: high carriage serotypes (6B, 9V, 19F and 23F) grew better than low carriage serotypes (7F, 14, 15B/C and 18C). Growth correlated with the case-fatality rates of serotypes reported in the literature. Capsule size in human cerebrospinal fluid also depended on serotype.
Conclusions: We propose that serotype-specific differences in disease severity observed in meningitis patients may, at least in part, be explained by differences in growth and capsule size in human cerebrospinal fluid. This information could be useful to guide future vaccine design.
Actions (login required)
 |
Edit item |